U.S. flag

An official website of the United States government

NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu) AND FGFR2-related craniosynostosis

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 28, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001313539.4

Allele description

NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu)

Gene:
FGFR2:fibroblast growth factor receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q26.13
Genomic location:
Preferred name:
NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu)
Other names:
NM_000141.4:c.755C>T(p.Ser252Leu); NM_001144913.1:c.755C>T(p.Ser252Leu); NM_001144915.1:c.488C>T(p.Ser163Leu); NM_001144916.1:c.410C>T(p.Ser137Leu); NM_001144917.1:c.755C>T(p.Ser252Leu); NM_001144918.1:c.410C>T(p.Ser137Leu); NM_001144919.1:c.488C>T(p.Ser163Leu); NM_022970.3:c.755C>T(p.Ser252Leu); NM_023029.2:c.488C>T(p.Ser163Leu)
HGVS:
  • NC_000010.11:g.121520163G>A
  • NG_012449.2:g.83296C>T
  • NM_000141.5:c.755C>TMANE SELECT
  • NM_001144913.1:c.755C>T
  • NM_001144914.1:c.749-4844C>T
  • NM_001144915.2:c.488C>T
  • NM_001144916.2:c.410C>T
  • NM_001144917.2:c.755C>T
  • NM_001144918.2:c.410C>T
  • NM_001144919.2:c.488C>T
  • NM_001320654.2:c.71C>T
  • NM_001320658.2:c.755C>T
  • NM_022969.1:c.755C>T
  • NM_022970.4:c.755C>T
  • NM_023029.2:c.488C>T
  • NP_000132.3:p.Ser252Leu
  • NP_000132.3:p.Ser252Leu
  • NP_001138385.1:p.Ser252Leu
  • NP_001138387.1:p.Ser163Leu
  • NP_001138388.1:p.Ser137Leu
  • NP_001138389.1:p.Ser252Leu
  • NP_001138390.1:p.Ser137Leu
  • NP_001138391.1:p.Ser163Leu
  • NP_001307583.1:p.Ser24Leu
  • NP_001307587.1:p.Ser252Leu
  • NP_075258.1:p.Ser252Leu
  • NP_075259.4:p.Ser252Leu
  • NP_075259.4:p.Ser252Leu
  • NP_075418.1:p.Ser163Leu
  • LRG_994t1:c.755C>T
  • LRG_994t2:c.755C>T
  • LRG_994:g.83296C>T
  • LRG_994p1:p.Ser252Leu
  • LRG_994p2:p.Ser252Leu
  • NC_000010.10:g.123279677G>A
  • NM_000141.4:c.755C>T
  • NM_000141.5:c.755C>T
  • NM_022970.3:c.755C>T
  • NR_073009.2:n.1043C>T
Protein change:
S137L
Links:
dbSNP: rs79184941
NCBI 1000 Genomes Browser:
rs79184941
Molecular consequence:
  • NM_001144914.1:c.749-4844C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000141.5:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144913.1:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144915.2:c.488C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144916.2:c.410C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144917.2:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144918.2:c.410C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144919.2:c.488C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320654.2:c.71C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320658.2:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022969.1:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022970.4:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_023029.2:c.488C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_073009.2:n.1043C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
FGFR2-related craniosynostosis
Identifiers:
MedGen: CN231480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001504038Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 28, 2023)
germlineclinical testing

PubMed (13)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2.

Oldridge M, Lunt PW, Zackai EH, McDonald-McGinn DM, Muenke M, Moloney DM, Twigg SR, Heath JK, Howard TD, Hoganson G, Gagnon DM, Jabs EW, Wilkie AO.

Hum Mol Genet. 1997 Jan;6(1):137-43.

PubMed [citation]
PMID:
9002682

Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis.

Sakai N, Tokunaga K, Yamazaki Y, Shida H, Sakata Y, Susami T, Nakakita N, Takato T, Uchinuma E.

J Craniofac Surg. 2001 Nov;12(6):580-5.

PubMed [citation]
PMID:
11711827
See all PubMed Citations (13)

Details of each submission

From Invitae, SCV001504038.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (13)

Description

This variant is also known as 934C>T. This missense change has been observed in individual(s) with FGFR2-related conditions (PMID: 9002682, 11711827, 27683237). This variant is present in population databases (rs79184941, gnomAD 0.01%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 252 of the FGFR2 protein (p.Ser252Leu). ClinVar contains an entry for this variant (Variation ID: 549484). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Ser252 amino acid residue in FGFR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7719344, 8651276, 9462761, 11390973, 22664175, 23495007, 24489893, 25867380). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on FGFR2 function (PMID: 9700203). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR2 protein function.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024